Gao Huan, Zhang Zirui, Deng Jiayu, Song Yanqing
College of Pharmacy, Jilin University, Changchun, Changchun, China.
Department of Clinical Pharmacy, the First Hospital of Jilin University, Changchun, China.
Front Immunol. 2025 Jul 7;16:1600206. doi: 10.3389/fimmu.2025.1600206. eCollection 2025.
Cathepsin S (CTSS), a lysosomal cysteine protease predominantly expressed in immune cells, governs inflammatory and immunological cascades through proteolytic activity. Beyond maintaining lysosomal proteostasis through protein degradation, CTSS executes dual immunomodulatory functions: intracellularly processing antigen-presenting molecules and modulating inflammatory signaling cascades; extracellularly activating protease-activated receptors (PARs) and remodeling the extracellular matrix (ECM). Its dysregulation drives pathology in autoimmune disorders, chronic inflammation, and neoplasia, establishing CTSS as a multifaceted therapeutic target. This review comprehensively explores the contributions of CTSS signaling in immune-mediated inflammatory diseases, critically evaluates its therapeutic potential, highlighting its significance in the development of innovative treatment strategies.
组织蛋白酶S(CTSS)是一种主要在免疫细胞中表达的溶酶体半胱氨酸蛋白酶,通过蛋白水解活性调控炎症和免疫级联反应。除了通过蛋白质降解维持溶酶体蛋白稳态外,CTSS还具有双重免疫调节功能:在细胞内加工抗原呈递分子并调节炎症信号级联反应;在细胞外激活蛋白酶激活受体(PARs)并重塑细胞外基质(ECM)。其失调会引发自身免疫性疾病、慢性炎症和肿瘤形成等病理过程,使CTSS成为一个多方面的治疗靶点。本综述全面探讨了CTSS信号在免疫介导的炎症性疾病中的作用,批判性地评估了其治疗潜力,强调了其在创新治疗策略开发中的重要性。